MedMira (MedMira) Days Sales Outstanding : 813.03 (As of Jan. 2024)

View and export this data going back to . Start your Free Trial

What is MedMira Days Sales Outstanding?

MedMira's average Accounts Receivable for the three months ended in Jan. 2024 was $0.99 Mil. MedMira's Revenue for the three months ended in Jan. 2024 was $0.11 Mil. Hence, MedMira's Days Sales Outstanding for the three months ended in Jan. 2024 was 813.03.

The historical rank and industry rank for MedMira's Days Sales Outstanding or its related term are showing as below:

MMIRF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 30.13 Med: 73.51 Max: 1178.2
Current: 1178.2

During the past 13 years, MedMira's highest Days Sales Outstanding was 1178.20. The lowest was 30.13. And the median was 73.51.

MMIRF's Days Sales Outstanding is ranked worse than
95.85% of 892 companies
in the Biotechnology industry
Industry Median: 73.125 vs MMIRF: 1178.20

MedMira's Days Sales Outstanding increased from Jan. 2023 (712.04) to Jan. 2024 (813.03).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

MedMira Days Sales Outstanding Historical Data

The historical data trend for MedMira's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMira Days Sales Outstanding Chart

MedMira Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

Days Sales Outstanding

Get a 7-Day Free Trial

30.42

49.31

122.88

487.00

1,068.85

MedMira Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Days Sales Outstanding	Get a 7-Day Free Trial															712.04	1,133.12	3,421.88	1,043.01	813.03

Competitive Comparison of MedMira's Days Sales Outstanding

For the Biotechnology subindustry, MedMira's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedMira's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MedMira's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where MedMira's Days Sales Outstanding falls into.

MedMira Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

MedMira's Days Sales Outstanding for the fiscal year that ended in Jul. 2023 is calculated as

	Days Sales Outstanding (A: Jul. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jul. 2022 )	+	Accounts Receivable (A: Jul. 2023 ))	/	count )	/	Revenue (A: Jul. 2023 )	*	Days in Period
=	( (0.966	+	0.955)	/	2 )	/	0.328	*	365
=	0.9605					/	0.328	*	365
=	1,068.85

MedMira's Days Sales Outstanding for the quarter that ended in Jan. 2024 is calculated as:

	Days Sales Outstanding (Q: Jan. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Oct. 2023 )	+	Accounts Receivable (A: Jan. 2024 ))	/	count )	/	Revenue (A: Jan. 2024 )	*	Days in Period
=	( (1.011	+	0.967)	/	2 )	/	0.111	*	365 / 4
=	0.989					/	0.111	*	365 / 4
=	813.03

MedMira (OTCPK:MMIRF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

MedMira Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of MedMira's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

MedMira (MedMira) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MedMira Inc (OTCPK:MMIRF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

47M:Germany MIR:Canada

Address

155 Chain Lake Drive, Suite 1, Halifax, NS, CAN, B3S 1B3

Website

https://www.medmira.com

MedMira Inc is a biotechnology company that is engaged in the business of research, development, and manufacturing of rapid diagnostics and technologies. The company has one reportable operating segment, rapid diagnostic products and services. The product line of the company includes RevealHIV which detects antibodies to HIV-1 and HIV-2 in whole blood, serum or plasma; H Pylori which detects antibodies in serum, plasma, and whole blood; syphilis which detects treponema pallidum antibodies in serum, plasma, and whole blood; among other products. The company generates revenue geographically from North America, Europe, Asia pacific. The majority of the revenue is generated from North America.